Carcinoid Heart Disease: From Pathophysiology to Treatment - ‘Something in the Way It Moves'

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Neuroendocrinology

• Publication date

  2015-04-09

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000381930PMID 25871411
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The clinical presentation and management of carcinoid heart disease.

  2014cited by this paper
• Carcinoid heart disease: current understanding and future directions.

  2014cited by this paper
• Determination of the Optimal Echocardiographic Scoring System to Quantify Carcinoid Heart Disease

  2014cited by this paper
• Prognosis of patients with carcinoid heart disease after valvular surgery.

  2014cited by this paper
• Telotristat etiprate, a novel serotonin synthesis inhibitor, in patients with carcinoid syndrome and diarrhea not adequately controlled by octreotide.

  2014cited by this paper
• New images in carcinoid heart disease.

  2012cited by this paper
• ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

  2011cited by this paper
• 5-HT 2A SEROTONIN RECEPTOR BIOLOGY: Interacting proteins, kinases and paradoxical regulation

  2011cited by this paper
• Risk factors for the development and progression of carcinoid heart disease.

  2011cited by this paper
• Outcomes, risks and complications of cardiac surgery for carcinoid heart disease.

  2011cited by this paper
• ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Neoplasms: Colorectal Neuroendocrine Neoplasms

  2011cited by this paper
• Serotonin receptors and heart valve disease--it was meant 2B.

  2011cited by this paper
• Features of Carcinoid Heart Disease Identified by 2- and 3-Dimensional Echocardiography and Cardiac MRI

  2010cited by this paper
• Activin A in Carcinoid Heart Disease: A Possible Role in Diagnosis and Pathogenesis

  2010cited by this paper
• Plasma CCN2/connective tissue growth factor is associated with right ventricular dysfunction in patients with neuroendocrine tumors

  2010cited by this paper
• Surgery for carcinoid heart disease: current outcomes, concerns and controversies.

  2010cited by this paper
• The expanded biology of serotonin.

  2009cited by this paper
• Simulation of crosstalk between small GTPase RhoA and EGFR-ERK signaling pathway via MEKK1

  2009cited by this paper
• Chromogranin-A and N-terminal pro-brain natriuretic peptide: an excellent pair of biomarkers for diagnostics in patients with neuroendocrine tumor.

  2009cited by this paper
• ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors:Echocardiography

  2009cited by this paper
• Magnetic Resonance Imaging of Carcinoid Heart Disease

  2009cited by this paper
• Management of patients undergoing multivalvular surgery for carcinoid heart disease: the role of the anaesthetist.

  2008cited by this paper
• Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease.

  2008cited by this paper
• Images in cardiovascular medicine: myocardial metastases of carcinoid visualized by 18F-dihydroxy-phenyl-alanine positron emission tomography.

  2008cited by this paper
• Analysis of 150 patients with carcinoid syndrome seen in a single year at one institution in the first decade of the twenty-first century.

  2008cited by this paper
• 5-hydroxytryptamine (5HT)-induced valvulopathy: compositional valvular alterations are associated with 5HT2B receptor and 5HT transporter transcript changes in Sprague-Dawley rats.

  2008cited by this paper
• The role of somatostatin analogues in the treatment of neuroendocrine tumours.

  2008cited by this paper
• Valvular regurgitation and surgery associated with fenfluramine use: an analysis of 5743 individuals

  2008cited by this paper
• ACC/AHA 2008 Guideline update on valvular heart disease: focused update on infective endocarditis: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angio

  2008cited by this paper
• Serotonin and Angiotensin Receptors in Cardiac Fibroblasts Coregulate Adrenergic-Dependent Cardiac Hypertrophy

  2008cited by this paper
• Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease.

  2008cited by this paper
• Tachykinins in endocrine tumors and the carcinoid syndrome.

  2008cited by this paper
• Carcinoid heart disease.

  2008cited by this paper
• Carcinoid Heart Disease

  2007cited by this paper
• CTGF, intestinal stellate cells and carcinoid fibrogenesis.

  2007cited by this paper
• Fibrotic heart-valve reactions to dopamine-agonist treatment in Parkinson's disease.

  2007cited by this paper
• Small bowel carcinoid (enterochromaffin cell) neoplasia exhibits transforming growth factor–β1‐mediated regulatory abnormalities including up‐regulation of C‐Myc and MTA1

  2007cited by this paper
• Carcinoid heart disease.

  2007cited by this paper
• Drugs and valvular heart disease.

  2007cited by this paper
• Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma

  2007cited by this paper
• Meta‐analysis of heart valve abnormalities in Parkinson's disease patients treated with dopamine agonists

  2007cited by this paper
• Therapeutic options for gastrointestinal carcinoids.

  2006cited by this paper
• Assessment of patent foramen ovale in carcinoid heart disease.

  2006cited by this paper
• The effects of cellular contraction on aortic valve leaflet flexural stiffness.

  2006cited by this paper
• Long-Term Serotonin Administration Induces Heart Valve Disease in Rats

  2005cited by this paper
• Neuroendocrine tumors of the gastrointestinal tract: recent advances in molecular genetics, diagnosis, and treatment

  2005cited by this paper
• 5-Hydroxytryptamine (5HT) Receptors in the Heart Valves of Cynomolgus Monkeys and Sprague-Dawley Rats

  2005cited by this paper
• Prognosis of Carcinoid Heart Disease: Analysis of 200 Cases Over Two Decades

  2005cited by this paper
• Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract

  2005cited by this paper
• Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)

  2005cited by this paper
• Current status of gastrointestinal carcinoids.

  2005cited by this paper
• TGF-beta1 and angiotensin networking in cardiac remodeling.

  2004cited by this paper
• Carcinoid heart disease: presentation, diagnosis, and management

  2004cited by this paper
• TGF-β1 and angiotensin networking in cardiac remodeling

  2004cited by this paper
• Carcinoid Tumors and Fibrosis: An Association with No Explanation

  2004cited by this paper
• Valvular Myofibroblast Activation by Transforming Growth Factor-&bgr;: Implications for Pathological Extracellular Matrix Remodeling in Heart Valve Disease

  2004cited by this paper
• Overexpression of the Serotonin 5-HT2B Receptor in Heart Leads to Abnormal Mitochondrial Function and Cardiac Hypertrophy

  2003cited by this paper
• Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases.

  2003cited by this paper
• Factors associated with progression of carcinoid heart disease.

  2003cited by this paper
• Carcinoid heart disease

  2003cited by this paper
• Molecular, pharmacological and functional diversity of 5-HT receptors.

  2002cited by this paper
• Carcinoid Heart Disease: Impact of Pulmonary Valve Replacement in Right Ventricular Function and Remodeling

  2002cited by this paper
• Serotonin mechanisms in heart valve disease I: serotonin-induced up-regulation of transforming growth factor-beta1 via G-protein signal transduction in aortic valve interstitial cells.

  2002cited by this paper
• The serotonin binding site of human and murine 5-HT2B receptors: molecular modeling and site-directed mutagenesis.

  2002cited by this paper
• Expression of Serotonin Receptors in Bone*

  2001cited by this paper
• Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

  2001cited by this paper
• Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours.

  2001cited by this paper
• Carcinoid heart disease: medical and surgical considerations.

  2001cited by this paper
• Evidence for Possible Involvement of 5-HT2B Receptors in the Cardiac Valvulopathy Associated With Fenfluramine and Other Serotonergic Medications

  2000cited by this paper
• Possible role of valvular serotonin 5-HT(2B) receptors in the cardiopathy associated with fenfluramine.

  2000cited by this paper
• Mitogenic and secretory responses of human valve interstitial cells to vasoactive agents.

  2000cited by this paper
• PDZ-dependent Activation of Nitric-oxide Synthases by the Serotonin 2B Receptor*

  2000cited by this paper
• Biological and Molecular Aspects of Gastroenteropancreatic Neuroendocrine Tumors

  2000cited by this paper
• Serotonin 2B receptor is required for heart development.

  2000cited by this paper
• Orthotopic liver transplantation for carcinoid tumour metastatic to the liver: anesthetic management

  2000cited by this paper
• 5-hydroxytryptamine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways.

  2000cited by this paper
• Clinicopathological profile as a basis for classification of the endocrine tumours of the gastroenteropancreatic tract.

  1999cited by this paper
• Increased intestinal non‐substance P tachykinin concentrations in malignant midgut carcinoid disease

  1999cited by this paper
• Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.

  1999cited by this paper
• Carcinoid heart disease and carcinoid syndrome: successful surgical treatment.

  1999cited by this paper
• Review article: roles played by 5‐hydroxytryptamine in the physiology of the bowel

  1999cited by this paper
• 5-Hydroxytryptamine2-family receptors (5-hydroxytryptamine2A, 5-hydroxytryptamine2B, 5-hydroxytryptamine2C): where structure meets function.

  1998cited by this paper
• Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction.

  1998cited by this paper
• Cross-talk between 5-Hydroxytryptamine Receptors in a Serotonergic Cell Line

  1998cited by this paper
• Incidence and evolution of carcinoid syndrome in the heart.

  1997cited by this paper
• Carcinoid heart disease with severe hypoxia due to interatrial shunt through patent foramen ovale.

  1997cited by this paper
• Cardiovascular complications of malignant carcinoid disease.

  1997cited by this paper
• Incidence and evolution of carcinoid syndrome in the heart.

  1997cited by this paper
• Ras Involvement in Signal Transduction by the Serotonin 5-HT2B Receptor (*)

  1996cited by this paper
• Immunohistochemical localisation of the serotonin 5‐HT2B receptor in mouse gut, cardiovascular system, and brain

  1996cited by this paper
• Sequential onset of three 5‐HT receptors during the 5‐hydroxytryptaminergic differentiation of the murine 1C11 cell line

  1996cited by this paper
• Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy. Evidence for brain natriuretic peptide as an "emergency" cardiac hormone against ventricular overload.

  1995cited by this paper
• Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography.

  1995cited by this paper
• Outcome of cardiac surgery for carcinoid heart disease.

  1995cited by this paper
• Expression of serotonin receptor mRNAs in blood vessels

  1995cited by this paper
• Carcinoid heart disease: early failure of an allograft valve replacement.

  1994cited by this paper
• Metastatic Carcinoid Tumors and the Malignant Carcinoid Syndrome

  1994cited by this paper
• Successful balloon dilatation of the pulmonary valve in carcinoid heart disease.

  1994cited by this paper
• Mitogenic effect of serotonin on vascular endothelial cells.

  1994cited by this paper
• Carcinoid Syndrome Due to a Primary Ovarian Carcinoid Tumour

  1993cited by this paper

• EndoCompass Project: Research Roadmap for Pituitary and Neuroendocrine Tumor Endocrinology

  2025cites this paper
• Carcinoid Heart Disease: A Rare Complication of Metastatic Neuroendocrine Tumor

  2025cites this paper
• Carcinoid heart disease – still a challenging diagnosis?

  2025cites this paper
• Carcinoid heart disease: how to manage it. A practical guide for the clinician

  2025influential citation
• Echocardiographic Evaluation of Carcinoid Heart Disease.

  2025cites this paper
• AIMN, ITANET, SIE joint position paper for the recognition, prevention and management of NET carcinoid syndrome and crises during peptide receptor radionuclide therapy

  2025cites this paper
• EndoCompass project: research roadmap for pituitary and neuroendocrine tumor endocrinology.

  2025cites this paper
• Early Detection of Myocardial Dysfunction by Two-Dimensional Speckle Tracking Echocardiography and Myocardial Work in Patients With Gastroenteropancreatic Neuroendocrine Neoplasms.

  2025cites this paper
• NET-Induced Carcinoid Heart Disease Affecting Both Tricuspid and Aortic Valves Due to Patent Foramen Ovale and Right/Left Shunt: A Multi-imaging Challenge to Nuclear Medicine.

  2024cites this paper
• Combined Treatment of Patients with Neuroendocrine Liver Metastases Accompanied by High Hormonal Activity and Uncontrolled Carcinoid Syndrome

  2024cites this paper
• Percutaneous Pulmonary Valve Implantation With Self‐Expanding Valves for Carcinoid Heart Diseases

  2024cites this paper
• Cardiac Surgery and Transcatheter Intervention for Valvular Heart Disease in Carcinoid Syndrome: Risk Factors, Outcomes, and Evolving Therapeutic Strategies

  2024cites this paper
• Management strategy of primary ovarian mucinous carcinoid tumor: A rare case report

  2024cites this paper
• Management of carcinoid heart disease.

  2024cites this paper
• Anesthetic key points in a patient with a terminal ileum neuroendocrine tumor and a rare carcinoid left heart disease presented for non-cardiac surgery: case report

  2024influential citation
• Two- and Three-dimensional Imaging in Carcinoid Heart Disease

  2024cites this paper
• Serum and Urinary 5-hydroxyindolacetic acid, Serotonin, Chromogranin A, and NT-proBNP for the detection of Carcinoid Heart Disease.

  2024cites this paper
• Bioprosthetic valve monitoring in patients with carcinoid heart disease

  2023cites this paper
• Balancing carcinoid crisis and right ventricular dysfunction during tricuspid and pulmonic valve replacement for carcinoid heart disease: A case report

  2023cites this paper
• Le cœur carcinoïde : physiopathologie, diagnostic, pronostic et prise en charge

  2023cites this paper
• Competing risk analysis of cardiovascular-specific mortality in typical carcinoid neoplasms of the lung: A SEER database analysis

  2023cites this paper
• Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

  2023cites this paper
• Torrential tricuspid insufficiency and severe pulmonary insufficiency secondary to ovarian tumour

  2023influential citation
• Improving outcomes in carcinoid heart disease – learning from a single centre

  2023cites this paper
• Management and outcomes of carcinoid heart disease with liver metastases of midgut neuroendocrine tumours

  2023cites this paper
• The role of N‐terminal pro‐brain natriuretic peptide, chromogranin A, and 5‐hydroxyindoleacetic acid in screening for carcinoid heart disease

  2023cites this paper
• Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor

  2023cites this paper
• Carcinoid Heart Disease Management: A Multi-Disciplinary Collaboration

  2023cites this paper
• Surgical Management of the Primary Tumor in Stage IV Small Intestinal Neuroendocrine Tumors: To Operate or Not to Operate, That Is the Question

  2023cites this paper
• Carcinoid Heart Disease-Induced Right-Sided Heart Failure as a Culprit for Significant Ascites

  2023cites this paper
• Carcinoid heart disease in patients with midgut neuroendocrine tumours

  2023influential citation
• Carcinoid Syndrome: Preclinical Models and Future Therapeutic Strategies

  2023cites this paper
• A 46-Year-Old Woman With Chronic Dyspnea and Diarrhea.

  2023cites this paper
• Rare case of concurrent suprasternal and cardiac metastasis from small bowel neuroendocrine tumour

  2022cites this paper
• Biochemical factors in the blood serum of neuroendocrine tumor patients with carcinoid syndrome

  2022cites this paper
• The Past, Present, and The Future of Carcinoid Heart Disease.

  2022cites this paper
• The Role of Echocardiography in the Diagnosis of Cardiac Involvement in a Rare Systemic Condition: The Carcinoid Heart Disease: A Case Report and Review of Literature

  2022cites this paper
• Four decades of experience with carcinoid heart disease: An analysis of 84 patients

  2022cites this paper
• Australasian Consensus Statement on the Identification, Prevention, and Management of Hormonal Crises in Patients with Neuroendocrine Neoplasms Undergoing Peptide Receptor Radionuclide Therapy

  2022cites this paper
• Patient with Carcinoid Syndrome and Severe Cardiac Disease with Both Tricuspid an Pulmonary Lesions

  2022cites this paper
• Telotristat ethyl reverses myxomatous changes in mice mitral valves

  2022cites this paper
• European Neuroendocrine Tumor Society (ENETS) 2022 Guidance Paper for Carcinoid Syndrome and Carcinoid Heart Disease

  2022cites this paper
• Hedinger Syndrome: A Rare Cardiac Manifestation of Carcinoid Syndrome

  2022cites this paper
• Traditional Chinese medicine combined with conventional treatment for the patients after percutaneous coronary intervention: A systematic review and meta-analysis

  2022cites this paper
• Pulsatile Inferior Vena Cava Contrast Material Reflux in Carcinoid Heart Disease.

  2022cites this paper
• Elevated Serotonin and NT-proBNP Levels Predict and Detect Carcinoid Heart Disease in a Large Validation Study

  2022cites this paper
• Surgical Correction of Carcinoid Heart Disease Improves Liver Function and 5-Hydroxyindoleacetic Acid Levels

  2022cites this paper
• The prevalence, operations, and outcomes of carcinoid heart disease.

  2022cites this paper
• Carcinoid heart disease: The rare and obscure becomes screened and well known.

  2022cites this paper
• Treatment of neuroendocrine tumours with 177Lu‐peptide receptor radionuclide therapy: Challenging clinical scenarios and their management

  2022cites this paper
• Update in carcinoid heart disease - the heart of the matter

  2021cites this paper
• Multimodality Imaging in the Evaluation and Treatment of Pulmonary Valve Disorders

  2021cites this paper
• Cardiovascular Mortality Risk among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Registry-Based Analysis

  2021cites this paper
• Recent Advances in the Diagnosis and Management of Carcinoid Syndrome.

  2021cites this paper
• Serotonin and Systemic sclerosis. An emerging player in pathogenesis.

  2021cites this paper
• A forgotten diagnosis in right heart failure: A case report and literature review

  2021cites this paper
• Carcinoid syndrome and its sequelae

  2021cites this paper
• CardioOncology

  2021cites this paper
• Synoptic reporting of echocardiography in carcinoid heart disease (ENETS Carcinoid Heart Disease Task Force)

  2021cites this paper
• Circulating Biochemical Markers of Gastro-Entero-Pancreatic (GEP) Neuroendocrine Neoplasms (NENs)

  2021cites this paper
• Carcinoid syndroma - diagnosis and management.

  2021cites this paper
• Changes in Carcinoid Syndrome Symptoms Among Patients Receiving Telotristat Ethyl in US Clinical Practice: Findings from the TELEPRO-II Real-World Study

  2021cites this paper
• Multicenter, Observational Study of Lanreotide Autogel for the Treatment of Patients with Neuroendocrine Tumors in Routine Clinical Practice in Germany and Austria

  2021cites this paper
• Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

  2021cites this paper
• A 33-year follow-up after valvular surgery for carcinoid heart disease.

  2021cites this paper
• CMAR_A_330429 7439..7446

  2021cites this paper
• Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series

  2021cites this paper
• Neuroendocrine neoplasms of the digestive system- current classification and terminology

  2021cites this paper
• Gastroenteropancreatic neuroendocrine neoplasms: A clinical snapshot

  2021cites this paper
• Carcinoid Heart Disease: a Review

  2021cites this paper
• Tumor Heterogenity in Gastro-Entero-Pancreatic Neuroendocrine Neoplasia

  2021cites this paper
• Multi-Modality Imaging for Interventions in Tricuspid Valve Disease

  2021cites this paper
• Managing carcinoid heart disease in patients with neuroendocrine tumours.

  2020cites this paper
• Carcinoid Heart Disease

  2020cites this paper
• Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature

  2020cites this paper
• Update on Pathophysiology, Treatment, and Complications of Carcinoid Syndrome

  2020cites this paper
• Carcinoid Heart Disease: Prognostic Value of 5-Hydroxyindoleacetic Acid Levels and Impact on Survival: A Systematic Literature Review

  2020cites this paper
• Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency

  2020cites this paper
• A Budget Impact Model of the Addition of Telotristat Ethyl Treatment to the Standard of Care in Patients with Uncontrolled Carcinoid Syndrome

  2020cites this paper
• Carcinoid Right Heart Disease

  2020cites this paper
• Insuficiencia cardíaca por un síndrome carcinoide: un reto diagnóstico. Reporte de caso

  2020cites this paper
• General Characteristics and Prognostic Factors on Survival in Neuroendocrine Tumor Patients Diagnosed with Carcinoid Syndrome: Erciyes Multidisiplinary Neuroendocrine Tumor (NET) Group Experience

  2020cites this paper
• Antiproliferative Effects of Telotristat Ethyl in Patients with Neuroendocrine Tumors: The TELEACE Real-World Chart Review Study

  2020cites this paper
• CMAR_A_261257 6607..6614

  2020cites this paper
• Features of carcinoid heart disease identified by cardiac computed tomography.

  2020cites this paper
• Carcinoid Heart Disease: Pathophysiology, Pathology, Clinical Manifestations, and Management

  2020cites this paper
• EXOPHTALMOS REVEALING A CARCINOID HEART DISEASE: A CASE REPORT

  2020cites this paper
• Carcinoid Heart Disease: How to Diagnose and Treat in 2020?

  2020cites this paper
• A multidisciplinary approach to the management of gastroenteropancreatic neuroendocrine tumors - a case report

  2020cites this paper
• First Case of Regression of Carcinoid Heart Disease on Serial Transthoracic Echocardiograms following Octreotide Monotherapy in a Patient with Metastatic Pancreatic Neuroendocrine Tumor

  2020cites this paper
• Perioperative Manage- ment of Patients with Carcinoid Syndrome/ Neuroendocrine Neoplasm

  2020cites this paper
• Carcinoid Heart Disease and Decreased Overall Survival among Patients with Neuroendocrine Tumors: A Retrospective Multicenter Latin American Cohort Study

  2019cites this paper
• Paraneoplastic syndromes and other systemic disorders associated with neuroendocrine neoplasms.

  2019cites this paper
• Multidisciplinary team management of carcinoid heart disease

  2019cites this paper
• Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis.

  2019cites this paper
• Hedinger Syndrome: Report of Two Cases

  2019influential citation
• Carcinoid Syndrome

  2019cites this paper
• Carcinoid Heart Disease: Review of Current Knowledge.

  2019cites this paper
• Carcinoid heart disease involving the left heart: a case report and biomarker analysis

  2019influential citation
• Carcinoid Heart Disease: A Guide for Clinicians.

  2019cites this paper